Tissue holds the answers in drug development; the question is how to read it consistently and at scale. Should your tissue be analyzed manually or digitally? Flagship may hold the answer.
News
Scientist Spotlight: Chandler Callaway, PhD
Dr. Chandler Callaway is a scientist at Flagship Biosciences, specializing in assay design and analysis. Chandler loves collaborating with clients to solve diverse scientific problems. He brings a positive attitude and a big-picture mindset to his work, which helps...
Scientist Spotlight: Lenka Sinik, PhD
In this Scientist Spotlight, we sit down with Lenka Sinik, Head of the Science Team in Colorado, to discuss her journey into science, the excitement of working at the intersection of technology and precision medicine, and how her expertise is helping biopharma...
Scientist Spotlight: Roger Pearce, MS
Roger Pearce is an Image Analysis Services Manager at Flagship Biosciences. Through expertise in Image Analysis and Digital Pathology, Pearce and his team strive to solve problems for both internal and external clients, pushing their skills and technology to their...
Scientist Spotlight: David Henderson, PhD
Dr. Henderson is Vice President of Computational & Imaging Sciences at Flagship. With a passion for innovative technology and solving problems for clients, Dr. Henderson not only inspires his team but also pushes the boundaries of what’s possible in our industry....
Flagship Biosciences and Offspring Biosciences Partner to Provide Complete Global Assay Development Services from Target Identification to Companion Diagnostics
Unlocking the combined value of Offspring’s innovative pre-clinical solutions with Flagship’s clinical trial data-driven assay solutions. Broomfield, CO, USA and Södertälje, Sweden – January 23, 2024 – Flagship Biosciences, a leader in spatial biology and biomarker...
Sign up to receive industry and company news, including The Cut Point, Flagship’s quarterly e-newsletter.
Recent Posts
PUBLICATIONS
White Paper: Manual vs Digital Image Analysis
Tissue holds the answers in drug development; the question is how to read it consistently and at scale. Should your tissue be analyzed manually or digitally? Flagship may hold the answer.
H-Score Paradigm in Image Analysis is Superior to Percent Fiber Positivity in Measuring Response to Therapy in Dystrophinopathy
Author(s): Maria Szwarc, Ph.D., Flagship Biosciences, Inc., Chandler S. Callaway, Ph.D., Flagship Biosciences, Inc., G. Dave Young, DVM, Flagship Biosciences, Inc., Nathaniel H. Atwood, B.S., Flagship Biosciences, Inc., Will Paces, MAS, Flagship Biosciences, Inc.,...
Digital and Spatial Characterization of PD-L1 Expression and IVD Performance in the Immune Landscape of Head and Neck Squamous Cell Carcinoma: A Multimodal Approach
Abstract: The anti-PD-L1 antibody (22C3) is used as a companion diagnostic for successful checkpoint inhibitor therapy in head and neck squamous cell carcinoma. The positive predictive value of this assay, however, is less than ideal as a high PD-L1 score does not...
EVENTS
2nd Annual Spatial Biology for Drug Development Summit
Meet us at the 2nd annual Spatial Biology for Drug Development Summit. We’re excited to be a Program Partner for the Spatial Biology for Drug Development Summit, returning to Boston for a 2nd year, October 22-24. This year, we’ll dive into the latest in spatial omics...
14th Annual World Clinical Biomarkers and Companion Diagnostics Summit
Meet with us in Boston for World CB & CDx.We’re thrilled to be a Spotlight Partner for the 14th World Clinical Biomarkers and Companion Diagnostics Summit. Join us there to exchange insights with biotech and pharma leaders, researchers, and scientists and to discuss...
Spatial Biology East Coast US 2024
Meet with us at booth #25. As a Gold Sponsor for the third annual Spatial Biology East Coast Congress in Boston, we hope you’ll join our experts and over 350 other industry leaders to discuss the transforming field of spatial biology. Examine how spatial biology can...